| November 2008 |
Supporting modern standards of corporate governance more..
Roche signs definitive agreement to acquire Memory Pharmaceuticals more..
New phase III study of Avastin in advanced breast cancer meets its primary endpoint of increasing the time patients live without their disease getting worse more..
RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis more..
Tarceva brings new hope to patients with advanced non-small cell lung cancer more..
Clinical studies as a logistical challenge more.. |
 |
| October 2008 |
Roche posts sustained double-digit sales growth for the first nine months of 2008 more..
Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia more..
Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer more..
Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy more..
Roche invests 215 million Swiss francs in diagnostics facility at Penzberg more.. |
|
| September 2008 |
New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status more..
Roche to present data showing progress in treating lung, gastric and brain cancers at ESMO more.. |
|
| August 2008 |
Chocos Village Project: contributions from Roche make a difference more..
Parallel imports of patented drugs: a critical reflexion more..
Blood Screening Team Wins 'Gold' at Olympic Games more..
Roche and Meda agree on product transactions more..
Roche continues to believe its Genentech proposal is fair and generous more..
Roche Continents: creativity and innovation in Arts and Science more.. |
|
| July 2008 |
FDA Advisory Committee recommends approval of Actemra for the treatment of rheumatoid arthritis more..
Using a novel sequencing system within RNAi therapeutic research more..
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics more..
Roche acquires Mirus to advance research in the field of RNAi delivery more..
Roche posts very good results: strong market outperformance - guidance confirmed more..
Experts in a dialogue on genetics and ethics more.. |
|
| June 2008 |
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment more..
New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis more..
Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials more..
Animal protection plays an important role in innovative research more.. |
|
| May 2008 |
Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer more..
Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer more..
Sustainability at Roche - an overview more..
New Global Roche Position: Pharmaceuticals in the Environment more.. |
|
| April 2008 |
Roche employees support gift charity for Indian children more..
Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets more..
Actemra approved in Japan to treat patients with rheumatoid arthritis more..
Alzheimer, a disease worth researching more..
Roche fully acquires privately-owned biotech company Piramed more.. |
|
| March 2008 |
Roche says drug for cholesterol does well in tests more..
New Roche Energy Efficiency Standard Translates Commitment Into Action more..
Developing a new generation of diagnostics systems more..
Roche raises dividend by 35 percent more.. |
|
| February 2008 |
Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer more..
FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer more..
Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint more..
CNS Biomarker Day in Basel: bridging the gap between Pharma Research and Pharma Development more..
Conducting research experiments with great speed more.. |
|
| January 2008 |
Roche helps African, Asian companies make AIDS drug more..
Successful cooperation: from scientific breakthrough to therapy more.. |
|
| December 2007 |
| PCR - test method enriching medical diagnosis more.. |
|
| November 2007 |
| Roche arthritis drug effective in late-stage trial more.. |
|
| October 2007 |
Roche Considering Legal Options In Patent Litigation Case more..
Tarceva approved for lung cancer in Japan more..
European licence for Roche HIV drug Viracept re-established by European Commission more..
Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks more..
Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply more.. |
